ADAMTSL5 and CDH11: putative epigenetic markers for therapeutic resistance in acute lymphoblastic leukemia

QR Code

ADAMTSL5 and CDH11: putative epigenetic markers for therapeutic resistance in acute lymphoblastic leukemia

Background and objectives: DNA hypermethylation has been linked to poor treatment outcome in childhood acute lymphoblastic leukemia (ALL). Genes differentially methylated in the chemoresponsive pre-B-ALL compared to chemoresistant pre-B-ALL cases provide potential prognostic markers. Methods: DNA me...

Full description

Bibliographic Details
Main Authors:	Abdullah, Maha, Choo, Chee Wei, Alias, Hamidah, Abdul Rahman, Eni Juraidah, Mohd Ibrahim, Hishahshah, Jamal, Rahman, Hussin, Noor Hamidah
Format:	Article
Language:	English
Published:	Maney Publishing 2017
Online Access:	http://psasir.upm.edu.my/id/eprint/60765/ http://psasir.upm.edu.my/id/eprint/60765/1/ADAMTSL5%20and%20CDH11%20putative%20epigenetic%20markers%20for%20therapeutic%20resistance%20in%20acute%20lymphoblastic%20leukemia.pdf

Similar Items

Increased regulatory T cells in acute lymphoblastic leukemia patients
by: Idris, Siti Zuleha, et al.
Published: (2015)

Targeting the bone marrow microenvironment: A novel therapeutic strategy for pre-B acute lymphoblastic leukemia
by: Kotecha, R., et al.
Published: (2019)

Effects of acute lymphoblastic leukemia on ceruloplasmin oxidase, copper and several markers of oxidative damage, in children
by: Mehdi, Wesen Adel, et al.
Published: (2015)

A putative homologue of CDC20/CDH1 in the malaria parasite is essential for male gamete development
by: Guttery, David S., et al.
Published: (2012)

CD26: A prognostic marker of acute lymphoblastic leukemia in children in the post remission induction phase
by: Mende, Atheer Awad, et al.
Published: (2015)

Preclinical efficacy of gemcitabine in MLL-rearranged infant acute lymphoblastic leukemia
by: Wander, P., et al.
Published: (2020)

Exposure to diagnostic radiological procedures and the risk of childhood acute lymphoblastic leukemia
by: Bailey, H., et al.
Published: (2010)

Home paint exposures and risk of childhood acute lymphoblastic leukemia: findings from the Childhood Leukemia International Consortium
by: Bailey, H., et al.
Published: (2015)

Antileukemogenesis of nypa fruticans on acute lymphoblastic leukemia – a preliminary study in vitro
by: Mamat, Suhana, et al.
Published: (2015)

Exposure to professional pest control treatments and the risk of childhood acute lymphoblastic leukemia
by: Bailey, H., et al.
Published: (2011)

The bone marrow microenvironment of pre-B acute lymphoblastic leukemia at single-cell resolution
by: Anderson, D., et al.
Published: (2020)

Preclinical Evaluation of Carfilzomib for Infant KMT2A-Rearranged Acute Lymphoblastic Leukemia.
by: Cheung, Laurence, et al.
Published: (2021)

Exposure to house painting and the use of floor treatments and the risk of childhood acute lymphoblastic leukemia
by: Bailey, H., et al.
Published: (2011)

Genomic landscape of childhood acute lymphoblastic leukemia in Malaysia: insights from array-CGH
by: Ismail, Azli, et al.
Published: (2025)

Anticancer potential of Damnacanthal and Nordamnacanthal from Morinda elliptica roots on T-lymphoblastic leukemia cells
by: Saiful Yazan, Latifah, et al.
Published: (2021)

CDH ensures better public governance, says analyst
by: The Sun, .
Published: (2024)

Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemia.
by: Roels, Juliette, et al.
Published: (2020)

Maternal folate and other vitamin supplementation during pregnancy and risk of acute lymphoblastic leukemia in the offspring
by: Milne, Elizabeth, et al.
Published: (2010)

Romidepsin enhances the efficacy of cytarabine in vivo, revealing histone deacetylase inhibition as a promising therapeutic strategy for KMT2A-rearranged infant acute lymphoblastic leukemia
by: Cheung, Laurence, et al.
Published: (2019)

Systematic chemical and molecular profiling of MLL-rearranged infant acute lymphoblastic leukemia reveals efficacy of romidepsin
by: Cruickshank, M., et al.
Published: (2017)

RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia.
by: Matthijssens, Filip, et al.
Published: (2021)

Influence of wild-type MLL on glucocorticoid sensitivity and response to DNA-damage in pediatric acute lymphoblastic leukemia
by: Beesley, A., et al.
Published: (2010)

Disseminated fusariosis and endogenous fungal endophthalmitis in acute lymphoblastic leukemia following platelet transfusion possibly due to transfusion-related immunomodulation
by: Tan, Aik Kah, et al.
Published: (2011)

Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma
by: De Smedt, Renate, et al.
Published: (2020)

CDH USM SAMPAIKAN SUMBANGAN KEPADA GOLONGAN ASNAF PARIT BUNTAR PERAK
by: MPRC, Pusat Media & Perhubungan Awam
Published: (2017)

Amelioration of human acute lymphoblastic leukemia (ALL) cells by ZnO-TiO2-Chitosan-Amygdalin nanocomposites
by: Elderdery, Abozer Y., et al.
Published: (2022)

Suberoylanilide hydroxamic acid – a potential epigenetic therapeutic agent for lung fibrosis?
by: Wang, Z., et al.
Published: (2009)

Molecular mechanism underlying aberrant expression of the connective tissue growth factor in paediatric pre-B cell acute lymphoblastic leukemia
by: Welch, Mathew D.
Published: (2011)

Ultrastructural and morphological effects in T-lymphoblastic leukemia CEM-SS cells following treatment with nordamnacanthal and damnacanthal from roots of Morinda elliptica
by: Latifah, Saiful Yazan, et al.
Published: (2022)

Minimal residual disease status in childhood acute lymphoblastic leukaemias by flow cytometry and their clinical and haematological features
by: Azma RZ,, et al.
Published: (2010)

In Vitro evaluation of T- cell Acute Lymphoblastic Leukemia cell line response to a combination of dual anticancer agent: SRJ23 and Hydroxyurea
by: Khalid, Bahariah, et al.
Published: (2024)

Early lineage switch from T-acute lymphoblastic leukaemia to common B-all.
by: Hafiza, A, et al.
Published: (2011)

Molecular genetic and epigenetic mechanisms of primary and secondary resistance to imatinib mesylate treatment in ph chromosome positive chronic myeloid leukemia patients
by: Elias, Marjanu Hikmah
Published: (2015)

New therapeutic opportunities from dissecting the pre-B leukemia bone marrow microenvironment
by: Cheung, Laurence, et al.
Published: (2018)

S-phase fraction and pro-inflammatory cytokine expressions in acute lymphoblastic leukaemia
by: Abdullah, Maha, et al.
Published: (2005)

Zerumbone-loaded nanostructured lipid carrier induces G2/M cell cycle arrest and apoptosis via mitochondrial pathway in a human lymphoblastic leukemia cell line
by: Rahman, Heshu Sulaiman, et al.
Published: (2014)

The novel role of the B-cell lymphoma/leukemia 11A (BCL11A) gene in β-thalassaemia treatment
by: Lai, Mei I, et al.
Published: (2023)

circRNAs as Epigenetic Regulators of Integrity in Blood–Brain Barrier Architecture: Mechanisms and Therapeutic Strategies in Multiple Sclerosis
by: D'Aversa, Elisabetta, et al.
Published: (2024)

Reviewing the epigenetics of schizophrenia
by: Cromby, John, et al.
Published: (2016)

Forensic short tandem repeat markers alteration in leukemia cells and breast cancer tissues
by: Omar, Izzah Syahira
Published: (2025)